indolepropionic acid has been researched along with Metabolic Syndrome in 1 studies
indolepropionic acid: structure in third source
3-(1H-indol-3-yl)propanoic acid : An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menni, C | 1 |
| Hernandez, MM | 1 |
| Vital, M | 1 |
| Mohney, RP | 1 |
| Spector, TD | 1 |
| Valdes, AM | 1 |
1 other study available for indolepropionic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Circulating levels of the anti-oxidant indoleproprionic acid are associated with higher gut microbiome diversity.
Topics: Aged; Antioxidants; Bacteria; Coenzyme A Ligases; Cohort Studies; Diet; Feces; Female; Gastrointesti | 2019 |